Benefits from angiotensin-converting enzyme inhibitor 'beyond blood pressure lowering': Beyond blood pressure or beyond the brachial artery?

Journal of Hypertension

Volumn 23, Issue 3, 2005, Pages 551-556

  Hirata, Kozo ^a   Vlachopoulos, Charalambos ^a   Adji, Audrey ^a   O'Rourke, Michael F ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b ST VINCENT'S CLINIC   (Australia)

Author keywords

Angiotensin converting enzyme inhibitors; Aortic systolic pressure; Arterial stiffness; Arterial tonometry; Wave reflection

Indexed keywords

ATENOLOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PLACEBO; RAMIPRIL;

ADULT; AGED; AORTA PRESSURE; ARTERIAL PRESSURE; ARTICLE; BRACHIAL ARTERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY RISK; CROSSOVER PROCEDURE; DIABETES MELLITUS; DOUBLE BLIND PROCEDURE; FEMALE; HEART INFARCTION; HEART RATE; HIGH RISK PATIENT; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; PULSE WAVE; RADIAL ARTERY; RANDOMIZED CONTROLLED TRIAL; SMOKING; STATISTICAL ANALYSIS; TONOMETRY;

EID: 17144409806     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000160211.56103.48     Document Type: Article

References (27)

1. The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, Ramipril, on cardiovascular events in high-risk patients. N Engl J Med 2000; 342:145-153.
2. Dahlof B, Devereux RB, Kjeldsen SE, Julius S, Beevers G, de Faire U, et al., for the LIFE study group. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet 2002; 359:995-1003.
3. Brunner H, Gavras H. Angiotensin blockade for hypertension: a promise fulfilled (Commentary). Lancet 2002; 359:990-992.
4. O'Rourke MF. Effect of Ramipril on cardiovascular events in high-risk patients. [Letter to the editor]. N Engl J Med 2000; 343:64-65.
5. Mourad JJ, Safar ME, O'Rourke MF. Who is fooling us? [Letter to the editor]. Lancet 2002; 360:89.
6. Mitchell GF, Pfeffer MA, Finn PV, Pfeffer JM. Equipotent antihypertensive agents variously affect pulsatile hemodynamics and regression of cardiac hypertrophy in spontaneously hypertensive rats. Circulation 1996; 94:2923-2929.
7. Griffin KA, Abu-Amarah I, Picken M, Bidani AK. Renoprotection by ACE inhibition or aldosterone blockade is blood pressure-dependent. Hypertension 2003; 41:201-206.
8. Kelly RP, Gibbs HH, O'Rourke MF, Daley JE, Morgan JJ, Avolio AP. Nitroglycerin has more favourable effects on left ventricular afterload than apparent from measurement of pressure in a peripheral artery. Eur Heart J 1990; 11:138-144.
9. Takazawa K, O'Rourke MF, Fujita M, Tanaka N, Kurosu F, Ibukiyama C. Estimation of ascending aortic pressure from radial arterial pressure using a generalized transfer function. Z Kardiol 1996; 85(suppl 3):137-139.
10. Simkus GJ, Fitchett DH. Radial arterial pressure measurements may be a poor guide to the beneficial effects of nitroprusside on left ventricular systolic pressure in congestive heart failure. Am J Cardiol 1990; 66:323-326.
11. Pauca AL, O'Rourke MF, Kon ND. Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. Hypertension 2001; 38:932-937.
12. Kelly RP, Daley JE, Avolio AP, O'Rourke MF. Arterial dilation and reduced wave reflection: benefit of dilevalol in hypertension. Hypertension 1989; 14:14-21.
13. Ting CT, Chen CH, Chang MS, Yin FC. Short-and long-term effects of antihypertensive drugs on arterial reflections, compliance and impedance. Hypertension 1995; 26:524-530.
14. Asmar RG, London GM, O'Rourke MF, Safar ME. for the REASON Project Coordinators and Investigators. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/ indapamide combination in hypertensive patients: a comparison with atenolol. Hypertension 2001; 38:922-926.
15. Stokes GS, Barin ES, Gilfillan KL. Effects of isosorbide mononitrate and All inhibition on pulse wave reflection in hypertension. Hypertension 2003; 41:297-301.
16. London GM, Asmar RG, O'Rourke MF, Safar ME. on behalf of the REASON Project Investigators. Mechanism(s) of selective systolic blood pressure reduction after a low-dose combination of perindopril/ indapamide in hypertensive subjects: comparison with atenolol. J Am Coll Cardiol 2004; 43:92-99.
17. Nichols WW, O'Rourke MF. McDonald's blood flow in arteries, 4th edition. London: Arnold; 1998.
18. Chen CH, Nevo E, Fetics B, Pak PH, Yin FCP, Maughan WL, Kass DA. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure: Vvalidation of generalized transfer function. Circulation 1997; 95:1827-1836.
19. Asmar R, Benetos A, Topouchian J, Laurent P, Pannier B, Brisac AM, et al. Assessment of arterial distensibility by automatic pulse wave velocity measurement: validation and clinical application studies. Hypertension 1995; 26:485-490.
20. O'Rourke MF. Ascending aortic pressure wave indices and cardiovascular disease [Editorial]. Am J Hypertens 2004; 17:721-723.
21. London GM, Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME. Arterial wave reflections and survival in end-stage renal failure. Hypertension 2001; 38:434-438.
22. Safar ME, Blacher J, Pannier B, Guerin AP, Marchais SJ, Guyonvarc'h PM, et al. Central pulse pressure and mortality in end-stage renal disease. Hypertension 2002; 39:735-738.
23. Mancia G, Parati G. BP monitoring and antihypertensive treatment. J Hypertens 2004; 22:435-445.
24. Boutouyrie P, Bussy C, Lacolley P, Girerd X, Laloux B, Laurent S. Association between local pulse pressure, mean blood pressure, and large artery remodelling. Circulation 1999; 100:1387-1393.
25. Mackenzie J. The study of the pulse: arterial, venous and hepatic, and of the movements of the heart. Edinburgh: Young J. Pentland; 1902.
26. Karamanoglu M, O'Rourke MF, Avolio AP, Kelly RP. An analysis of the relationship between central aortic and peripheral upper limp pressure waves in man. Eur Heart J 1993; 14:160-167.
27. Kurtz TW. False claim of blood pressure-independent protection by blockade of the renin aldosterone system? [Editorial]. Hypertension 2003; 41:193-196.